1417715-70-8

Basic information

• Product Name: C₁₇H₁₈N₆O₂
• Synonyms: C₁₇H₁₈N₆O₂
• CAS NO: 1417715-70-8
• Molecular Weight: 338.369
• Mol File: 1417715-70-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₇H₁₈N₆O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₇H₁₈N₆O₂(1417715-70-8)
• EPA Substance Registry System: C₁₇H₁₈N₆O₂(1417715-70-8)

Safety Data

• Hazardous Substances Data: 1417715-70-8(Hazardous Substances Data)

Upstream product

• 1417715-69-5 2-(2-chloro-9-(4-methoxybenzyl)-6-oxo-6,9-dihydro-1H-purin-1-yl)acetonitrile 
• 74-89-5 methylamine 

Downstream Products

• 1417715-74-2 2-(2-bromo-5-methyl-6,9-dioxo-5,6,7,9-tetrahydro-1H-imidazo[1,2-a]purin-1-yl)methyl-4-fluorobenzonitrile 
• 1417715-75-3 2-(2-bromo-5-methyl-6,9-dioxo-5,6,7,9-tetrahydro-1H-imidazo[1,2-a]purin-3-yl)methyl-4-fluorobenzonitrile 
• 1417715-76-4 tert-butyl (R)-(1-(1-(2-cyano-5-fluorobenzyl)-5-methyl-6,9-dioxo-5,6,7,9-tetrahydro-1H-imidazo[1,2-a]purin-2-yl)piperidin-3-yl)carbamate 

Relevant articles and documents

TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS

The present invention is directed to novel tricyclic heterocycles of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.